AstraZeneca plc AZN shares are trading higher on Thursday.
The company announced a commercial supply deal with Oxford Biomedica for the manufacturing of its AZD1222 coronavirus vaccine candidate.
AstraZeneca is a British-Swedish multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, U.K. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology.
AstraZeneca shares were trading up 2.57% at $53.82 at the time of publication on Thursday. The stock has a 52-week high of $57.44 and a 52-week low of $36.15.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
